SILVERARC CAPITAL MANAGEMENT, LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 12, 2026, for the 2025 Q4 period, SILVERARC CAPITAL MANAGEMENT, LLC held in its portfolio 68 assets valued at $720,050,731 (i.e. $720.05M).

The most valuable assets in the portfolio included: ABIVAX SA ($56.94M), COGENT BIOSCIENCES INC ($44.23M), and UROGEN PHARMA LTD ($40.72M).

The chart below shows the top 10 valuable assets, and the table below shows the top 68 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.
Data Source: SEC.
Top Valuable Stocks in SILVERARC CAPITAL MANAGEMENT, LLC Portfolio
ABIVAX SA
COGENT BIOSCIENCES INC
UROGEN PHARMA LTD
KALVISTA PHARMACEUTICALS INC
CELCUITY INC
NUVALENT INC
DIANTHUS THERAPEUTICS INC
KODIAK SCIENCES INC
PRAXIS PRECISION MEDICINES I
IMMUNOME INC
SILVERARC CAPITAL MANAGEMENT, LLC - Stock Holdings in 13F Filings (SEC)
Items per page:
0 of 0
Name of Issuer No. of Shares Value ($) Class
ABIVAX SA 422193 56934837 SPONSORED ADS
COGENT BIOSCIENCES INC 1245254 44231422 COM
UROGEN PHARMA LTD 1738821 40723188 COM
KALVISTA PHARMACEUTICALS INC 2427118 39197956 COM
CELCUITY INC 375132 37415666 COM
NUVALENT INC 311430 31326744 COM
DIANTHUS THERAPEUTICS INC 750136 30913105 COM
KODIAK SCIENCES INC 1023122 28606491 COM
PRAXIS PRECISION MEDICINES I 82465 24305734 COM NEW
IMMUNOME INC 1126210 24190991 COM
FRACTYL HEALTH INC 9840041 21648090 COM
UNIQURE NV 720800 17248744 CALL
MONTE ROSA THERAPEUTICS INC 1029066 16135755 COM
VERACYTE INC 357558 15053192 COM
CG ONCOLOGY INC 361158 14995280 COM
RHYTHM PHARMACEUTICALS INC 135950 14552088 COM
SYNDAX PHARMACEUTICALS INC 642899 13507308 COM
BIOGEN INC 75412 13271758 COM
INSMED INC 71256 12401394 COM PAR $.01
CENTESSA PHARMACEUTICALS PLC 458203 11459657 SPONSORED ADS
VIRIDIAN THERAPEUTICS INC 348569 10847467 COM
ASCENDIS PHARMA A/S 49228 10497379 SPONSORED ADR
PFIZER INC 419134 10436437 COM
BENITEC BIOPHARMA INC 731717 9856228 COM NEW
AVALO THERAPEUTICS INC 524436 9523758 COM NEW
GUARDANT HEALTH INC 91914 9388096 COM
ORIC PHARMACEUTICALS INC 1116604 9133821 COM
VAXCYTE INC 148787 6865032 COM
TREVI THERAPEUTICS INC 541240 6776325 COM
GOSSAMER BIO INC 2135722 6620738 COM
SPYRE THERAPEUTICS INC 187737 6150264 COM NEW
LEXEO THERAPEUTICS INC 617608 6132847 COM
AMYLYX PHARMACEUTICALS INC 506242 6115403 COM
CERUS CORP 2814383 5797629 COM
COMPASS THERAPEUTICS INC 1051343 5645712 COM
SOLENO THERAPEUTICS INC 117485 5439556 COM
COMPUGEN LTD 3479805 5324102 ORD
CELLDEX THERAPEUTICS INC NEW 191074 5189570 COM NEW
OLEMA PHARMACEUTICALS INC 206280 5157000 COM
ERASCA INC 1317584 4901412 COM
KALVISTA PHARMACEUTICALS INC 290600 4693190 CALL
FULCRUM THERAPEUTICS INC 394650 4463492 COM
FULCRUM THERAPEUTICS INC 391900 4432389 CALL
AARDVARK THERAPEUTICS INC 303939 3989199 COM
C4 THERAPEUTICS INC 1994224 3808968 COM STK
SURROZEN INC 157323 3555500 COM NEW
CONTINEUM THERAPEUTICS INC 307540 3515182 CL A
MINERALYS THERAPEUTICS INC 94983 3446933 COM
RELAY THERAPEUTICS INC 398167 3368493 COM
ABEONA THERAPEUTICS INC 627738 3308179 COM NEW
TELA BIO INC 2647512 3124064 COM
UNIQURE NV 126047 3016305 SHS
TARSUS PHARMACEUTICALS INC 36124 2957833 COM
KYMERA THERAPEUTICS INC 34589 2691370 COM
ULTRAGENYX PHARMACEUTICAL IN 110000 2530000 CALL
NEXTCURE INC 176057 2498249 COM NEW
ELUTIA INC 2751314 1905835 CL A COM
SIONNA THERAPEUTICS INC 41460 1705664 COM
CYTOMX THERAPEUTICS INC 385974 1644249 COM
X4 PHARMACEUTICALS INC 357387 1429548 COM NEW
EDGEWISE THERAPEUTICS INC 42052 1043520 COM
RADIOPHARM THERANOSTICS LTD 187406 978259 SPONSORED ADS
4D MOLECULAR THERAPEUTICS IN 100000 750000 COM
ADAGIO MED HLDGS INC 515384 535999 COM
RAPPORT THERAPEUTICS INC 9659 293054 COM
PALISADE BIO INC 102108 239954 COM
IBIO INC 106000 204580 COM NEW
ROCKET PHARMACEUTICALS INC 104828 2547 *W EXP 09/02/202